These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15277425)

  • 1. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes?
    Elbein SC; Karim MA
    Diabetes Care; 2004 Aug; 27(8):1968-73. PubMed ID: 15277425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.
    Weng J; Macfarlane WM; Lehto M; Gu HF; Shepherd LM; Ivarsson SA; Wibell L; Smith T; Groop LC
    Diabetologia; 2001 Feb; 44(2):249-58. PubMed ID: 11270685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
    Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
    J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes.
    Edghill EL; Khamis A; Weedon MN; Walker M; Hitman GA; McCarthy MI; Owen KR; Ellard S; T Hattersley A; Frayling TM
    Diabet Med; 2011 Jun; 28(6):681-4. PubMed ID: 21569088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion.
    Møller AM; Ek J; Durviaux SM; Urhammer SA; Clausen JO; Eiberg H; Hansen T; Rousseau GG; Lemaigre FP; Pedersen O
    Diabetologia; 1999 Aug; 42(8):1011-6. PubMed ID: 10491763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.
    Hansen L; Urioste S; Petersen HV; Jensen JN; Eiberg H; Barbetti F; Serup P; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1323-6. PubMed ID: 10720084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
    Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
    J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
    Gragnoli C; Stanojevic V; Gorini A; Von Preussenthal GM; Thomas MK; Habener JF
    Metabolism; 2005 Aug; 54(8):983-8. PubMed ID: 16092045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population.
    Gragnoli C; Cronsell J
    Minerva Med; 2007 Jun; 98(3):163-6. PubMed ID: 17592437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.
    Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Eur J Endocrinol; 2000 Oct; 143(4):511-3. PubMed ID: 11022198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.
    Shiau MY; Huang CN; Liao JH; Chang YH
    J Endocrinol Invest; 2004 Dec; 27(11):1076-80. PubMed ID: 15754742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.
    Elbein SC; Wegner K; Kahn SE
    Diabetes Care; 2000 Feb; 23(2):221-7. PubMed ID: 10868835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the D76N polymorphism of insulin promoter factor-1 in predisposing to Type 2 diabetes.
    Owen KR; Evans JC; Frayling TM; Hattersley AT; McCarthy MI; Walker M; Hitman GA
    Diabetologia; 2004 May; 47(5):957-8. PubMed ID: 15170499
    [No Abstract]   [Full Text] [Related]  

  • 14. PDX1-MODY: A rare missense mutation as a cause of monogenic diabetes.
    Abreu GM; Tarantino RM; da Fonseca ACP; de Souza RB; Soares CAPD; Cabello PH; Rodacki M; Zajdenverg L; Zembrzuski VM; Campos Junior M
    Eur J Med Genet; 2021 May; 64(5):104194. PubMed ID: 33746035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans.
    Karim MA; Wang X; Hale TC; Elbein SC
    BMC Med Genet; 2005 Oct; 6():37. PubMed ID: 16229747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus.
    Celi FS; Negri C; Tanner K; Raben N; De Pablo F; Rovira A; Pallardo LF; Martin-Vaquero P; Stern MP; Mitchell BD; Shuldiner AR
    Diabetes Metab Res Rev; 2000; 16(5):370-7. PubMed ID: 11025561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency.
    Nicolino M; Claiborn KC; Senée V; Boland A; Stoffers DA; Julier C
    Diabetes; 2010 Mar; 59(3):733-40. PubMed ID: 20009086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IPF-1 gene variation and the development of type 2 diabetes.
    Silver K; Shetty A
    Mol Genet Metab; 2002 Mar; 75(3):287-9. PubMed ID: 11914043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
    Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.